Innovating Works

HORUS

Financiado
Health Outcomes from Raised Urban Settings
NCDs, especially diabetes and cardiovascular diseases (CVDs), are the leading causes of morbidity and mortality worldwide. CVDs kill more people globally than any other disease, accounting for 17.9 million deaths per year. Diabete... NCDs, especially diabetes and cardiovascular diseases (CVDs), are the leading causes of morbidity and mortality worldwide. CVDs kill more people globally than any other disease, accounting for 17.9 million deaths per year. Diabetes, on the other hand, accounts for 2 million deaths annually. These diseases have a greater impact on vulnerable populations. This increased prevalence among this population is related to a range of social and environmental factors, lifestyles, and the impact of behavioural determinants. Low-income communities, such as migrants or ethnic minorities, are still undertreated and unprotected by most of the healthcare systems with a lack of quality of care for NCDs and a lack of preventive measures specifically adapted for them. Thus, HORUS aims to tackle NCDs, especially diabetes and CVDs, in urban built environments among vulnerable populations, mainly low-income communities, migrants and ethnic minorities. In particular, it has a twofold objective. (1) First, to analyse and explore in depth the causal links between the characteristics of the urban built environment and the prevalence of NCD risk behaviours in an integrated, comprehensive and multi-approach manner. HORUS will focus on existing urban interventions modifying the physical-social and functional characteristics of the built environment with a significant impact on the prevalence of risk behaviours and, eventually, NCD outcomes. (2) And, secondly, to develop pilot interventions in three European countries –Spain, Croatia and The Netherlands– to promote behaviour change towards healthier lifestyles for empowering vulnerable populations, and to support citizens in making optimal use of the urban environment they live in while reducing NCD risk behaviours, especially those related to diabetes and CVDs. ver más
30/11/2026
UV
4M€
Duración del proyecto: 36 meses Fecha Inicio: 2023-11-13
Fecha Fin: 2026-11-30

Línea de financiación: concedida

El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-11-13
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
Presupuesto El presupuesto total del proyecto asciende a 4M€
Líder del proyecto
UNIVERSITAT DE VALÈNCIA (ESTUDI GENERAL) La universitat de valencia, como servicio publico que es, imparte las enseñanzas necesarias para la formacion de los estudiantes, la prepara...
Sin perfil tecnológico calculado